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Introduction
The most advanced malaria vaccine, RTS,S (trade name, 
Mosquirix), induces immune responses that target P. falciparum 
circumsporozoite protein (CSP), and thereby the pre-erythrocytic 
stages of malaria, and has been shown to be partially effective 
in delaying the time to clinical malaria episodes1. Alongside the 
RTS,S subunit vaccine, several other pre-erythrocytic stage vac-
cines are under development, based on subunit or whole-parasite 
vaccination2–5. Vaccination with the attenuated sporozoite vaccine 
PfSPZ resulted in a protective efficacy of ~48%, as quantified 
by differences in time to first positive blood smears in malaria- 
experienced adults in Mali6. The results of this and other vaccine 
trials and the efficient immunisation of malaria-naive individuals 
with multiple infected mosquito bites while receiving chloroquine7 
contrast with the limited epidemiological evidence of naturally 
acquired functional immunity to Plasmodium pre-erythrocytic 
stages, which could be possibly linked to the lower number of 
sporozoites in natural parasite inoculations or to the frequency 
of host-vector contacts. Individuals living in malaria-endemic 
regions can develop naturally acquired immunity against severe 
malaria disease and death8,9, but it is unclear whether immunity that 
reduces, entirely or partially, the probability of blood-stage infec-
tion after parasite inoculation develops following natural exposure9. 
The high incidence of blood-stage re-infection after effective 
anti-malarial treatment in adults living in malaria-endemic 
regions suggests that sterilizing immunity does not develop 
even after years of repeated infection10,11. Similarly, cohort stud-
ies that have analysed the relationship between age and risk of 
P. falciparum infection showed no evidence for complete pro-
tection against infection and conflicting evidence on whether 
naturally acquired immunity can result in a different time to 
patency12,13. One of the most detailed studies on this topic 
reported clear negative associations between age and the risk of 
clinical malaria or microscopy-detected malaria infection, but 
similar times to PCR-detected infection for all age groups. 
The study concluded no or very limited evidence for an age- 
dependent acquisition of immunity that protects from infection13.
Table 1. Study population.
Variable Value
Number of individuals 
Screened and parasite-free by microscopy 58
Presence of parasites post-treatment 6
Consent withdrawn 1
Monitored 51
Age in years, median (IQR) 7.1 (5.7–8.1)
Gender 
Female, % (N) 37.2 (N = 19)
Reported bed net use, % (N) 51.0 (26)
Haemoglobin levels at the beginning of 






Total number of weekly surveillance 
visits 222
Weekly visits/participant, median (IQR) 4 (2–6)
*First weekly visit. IQR, interquartile range.
Given the interest in pre-erythrocytic vaccines, studies are needed 
to understand natural protective immune responses that tar-
get sporozoite and liver-stages of malaria infection. Here, we 
determine the associations between responses affecting sporo-
zoite gliding motility, hepatocyte invasion and malaria infection 
risk assessed by weekly quantitative PCR (qPCR) in a cohort of 
schoolchildren from Burkina Faso exposed to intense malaria 
transmission.
Results
Study population and follow-up
Of the 58 school-aged children who were recruited and received 
treatment at enrolment, 6 were PCR-positive 3 weeks after 
dihydroartemisinin-piperaquine (DHA-PQ) administration and 
were not eligible to continue follow-up. One child who was only 
followed for one routine visit, when no infection was detected, 
and who withdrew from the study, did not have immune responses 
quantified and was not included in this analysis.
Parasitological and immunological data from the remaining 51 
children followed intensively were analysed (Table 1). Every 
week these study participants were screened for incident infec-
tions. All but one study participant had P. falciparum parasites 
detected by 18S qPCR during follow-up. Malaria infection 
caused clinical disease in 43/50 children. One child developed 
symptomatology suggestive of malaria, but no parasites were 
detected in samples collected before and during the clinical 
episode; data from this child were censored after the onset of 
      Amendments from Version 1
The manuscript has been modified to address the comments 
made by the three reviewers. The main modifications in this 
version are related to the discussion and interpretation of the 
results. We now mention that our approach might not have fully 
addressed the correlation between immune responses against 
asexual stage antigens and pre-erythrocytic immunity, and that 
the multivariate analysis performed that included both types of 
immunity revealed a non-significant association between infection 
risk and functional pre-erythrocytic-stage immune responses 
– these modifications can be seen in the Abstract, Results and 
Discussion section. In this version, we have also removed the 
term ‘sporozoite-specific’, that was used in the first version to 
describe the assay that assessed antibody responses against 
whole sporozoites, since we did not show the specificity of these 
responses. Additionally, we have included descriptive analysis 
on the relationship between sporozoite gliding and hepatocyte 
invasion assays. We have also included a few sentences 
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Figure 1. Time to malaria infection detection. Time-to-infection data from all study participants (N=51) are shown. The black line represents 
the percentage of the study population that remained uninfected at different time-points (y-axis). Circles indicate when individuals with first 
parasite detection at the start of the corresponding dashed line developed clinical symptoms. Time, x-axis, is relative to the confirmation of 
parasite clearance, 3 weeks after anti-malarial administration.
symptoms. The median time from confirmation of the absence 
of parasites (i.e. 3 weeks after anti-malarial treatment) to infec-
tion detection by nested PCR or onset of symptoms was 28 days; 
one child who did not have parasites detected by nested PCR was 
not included in this calculation. Similarly, the median time to 
parasite detection by 18S qPCR was 30 days. In Figure 1, both 
the times of first 18S qPCR positive result and, if applicable, 
of development of clinical disease are presented for all study 
participants.
Naturally acquired IgG and IgM antibodies targeting 
sporozoites
Malaria antigen-specific antibodies to pre-erythrocytic anti-
gens CSP, liver stage antigen (LSA-1) and to asexual lysate were 
determined in naturally exposed children and malaria-naive 
European donors by ELISAs. Antibody titres to the CSP pre-
erythrocytic antigen were on average low in naturally exposed 
children and not significantly different from malaria-naive donors 
(Figure 2A, P=0.11; non-parametric tests were used for all com-
parisons), while LSA-1 antibody levels were significantly higher 
in malaria-exposed children compared to malaria-naive donors 
(Figure 2B, P=0.006). As expected, asexual blood stage- 
specific antibody titers in naturally exposed children were higher 
compared to malaria-naive donors (Figure 2C, P<0.0001). In 
addition to antigen-specific assays, IgG and IgM antibodies 
recognizing Plasmodium sporozoites were quantified using fluo-
rescently labelled anti-IgG and anti-IgM antibodies by flow 
cytometric analysis. Levels of antibodies targeting whole spo-
rozoites were significantly higher in the study participants com-
pared to malaria-naive donors (Figure 2D, E, P=0.01 and 0.04 
for IgG and IgM, respectively). Strong correlations between IgG 
and IgM antibodies targeting whole sporozoites (Figure S1A in 
Extended data14, P=0.0005, Spearman’s ρ=0.75), and between 
CSP-IgG antibody levels and whole sporozoite IgG antibodies 
(Figure S1B in Extended data14, Spearman’s ρ=0.83, P<0.0001) 
were also observed.
Naturally acquired antibodies in children neutralize in vitro 
sporozoite gliding motility
The neutralizing activity of naturally acquired antibodies against 
sporozoite motility was determined in an in vitro assay. Sporo-
zoites pre-treated with PBS showed an average gliding trail sur-
face of 7,392 (95% confidence interval [CI] 4,151-9,388) pixels. 
To characterize the effect of human plasma on sporozoite glid-
ing motility that is independent of naturally acquired immu-
nity, sporozoites were incubated in the presence of plasma from 
malaria-naive individuals (n=5) and showed an average gliding 
trail surface of 1,427(95% CI 646.6-2,207) pixels, significantly 
greater than the gliding trail surface of sporozoites incubated with 
30 μg/ml of a monoclonal anti-CSP antibody, our positive 
control, 141 (95% CI 71.9-225.4) pixels.
Plasma from the majority of cohort participants reduced in vitro 
sporozoite gliding motility with a median gliding inhibition of 
59.6% (IQR 27.8-77.0%); incubation of sporozoites with plasma 
from three participants resulted in lower gliding trail surfaces 
than the positive control. We defined two groups: one with poor 
gliding inhibition (individuals whose plasma inhibited less than 
20% of sporozoite gliding motility, N=8) and the other with strong 
gliding inhibition (more than 80% gliding inhibition, N=8). The 
first group had similar gliding trail surface (median, 1,353; IQR, 
1,311.7-1,639.2) compared to malaria-naive donors (median 1605.7, 
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Figure 2. Naturally acquired pre-erythrocytic antibody levels and their functionality against sporozoite infectivity in vitro. Malaria 
antigen-specific antibody levels in children from Burkina Faso (n=51) and European malaria-naive adults (n=9) to the pre-erythrocytic 
antigens (A) circumsporozoite protein (CSP), (B) liver-stage antigen-1 (LSA-1), and (C) asexual lysate as an internal control were determined 
by ELISAs and expressed as arbitrary units (AU). The amount of (D) IgG and (E) IgM antibodies recognizing sporozoites was determined by 
flow cytometry and shown as the geometric mean fluorescence intensity (MFI). To this end, P. falciparum NF54 sporozoites were pre-treated 
with 10% heat-inactivated plasma from children from Burkina Faso (N=16) and malaria-naive adults (N=8) and stained with fluorescently 
labelled antibodies against IgG and IgM antibodies. (F) The gliding motility of P. falciparum NF54 sporozoites, pre-treated with plasma from 
children from Burkina Faso (N=51) and malaria-naive adults (N=5), was determined by in vitro gliding motility assays. Gliding trail length 
of sporozoites incubated with plasma from malaria-naive donors (N=5) or naturally exposed children who were poor (N=8) or strong (N=8) 
inhibitors of gliding motility are shown. (G) The percent hepatocytes invaded by P. falciparum NF54 sporozoites pre-treated with plasma from 
children from Burkina Faso (N=16) who were shown to be either poor (n=8) or strong (n=8) gliding inhibitors and malaria-naive adults (N=9) 
was determined by in vitro invasion assays in human hepatoma cells. Comparisons between multiple groups were tested with Kruskal-Wallis 
test with Dunn’s multiple comparison post hoc test.
IQR 824.3 - 1,652) (Figure 2F), whilst strong gliding inhibitors 
had a median trail surface of 186.2 (IQR 9.4 - 208.6), which was 
significantly lower compared to malaria-naive donors (Figure 2F, 
P<0.01). In vitro gliding inhibition did not correlate with LSA-1 
IgG antibody levels (P=0.11, Spearman’s ρ=0.23), but corre-
lated with CSP-specific IgG antibodies (Figure S2A in Extended 
data14, P<0.0001, Spearman’s ρ=0.76), whole sporozoite IgG 
(Figure S2B in Extended data14, P<0.0001, Spearman’s ρ=0.81) 
and IgM antibodies (Figure S2C in Extended data14, P=0.01, 
Spearman’s ρ=0.61). While levels of IgG and IgM antibodies 
targeting whole sporozoite did not significantly differ between 
poor gliding inhibitors and malaria-naive adults, whole sporozoite 
antibody levels of strong gliding inhibitors were significantly 
higher compared to poor gliding inhibitors (Figure S2D in 
Extended data14, P<0.0001 and P=0.005 for IgG and IgM anti-
bodies, respectively) and malaria-naive adults (Figure S2D, E 
in Extended data14, P<0.0001 and P=0.0006 for IgG and IgM 
antibodies, respectively). This suggests that quantitative differ-
ences in measured immune responses might explain variation 
in these functional phenotypes.
Antibodies in malaria-exposed children neutralize in vitro 
sporozoite infectivity of hepatocytes
The inhibitory effect of naturally acquired antibodies on in vitro 
sporozoite invasion of hepatocytes was also assessed in a selected 
number of samples shown to inhibit gliding motility strongly 
(n=8) or poorly (n=8). In vitro invasion was inhibited by naturally 
acquired antibodies (median invasion inhibition, 19.4% [IQR, 
15.2-40.9%]), and plasma from children categorized as strong 
gliding inhibitors (see previous section) also prevented hepato-
cyte invasion more effectively compared to malaria-naive donors 
(Figure 2G, P<0.001). 7/8 plasma samples from strong gliding 
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Figure 3. Effects of immune responses against liver- and blood-stage antigens on malaria infection risk. To assess the effect of 
immune responses on infection risk, children were classified based on whether the results of their assays were higher or lower than the study 
population median (see Results): in (A), vertically aligned cells represent the same participant, and orange cells indicate that assay results are 
higher than the median (see also Figure S4, that shows a scatter plot of circumsporozoite protein (CSP) antibody levels and immunity against 
asexual lysate). In (B), Kaplan-Meier curves for children with high and low circumsporozoite protein CSP responses and gliding inhibition (GI) 
phenotypes are presented (N = 51); in (C), curves for participants categorized based on their responses to asexual stage antigens (AL) are 
shown (N = 51). In both panels (B) and (C), the y-axis corresponds to the percentage of the population uninfected at different time points.
inhibitors reduced hepatocyte invasion by 20% or more, whereas 
only 2/8 poor gliding inhibitors inhibited at least 20% of hepa-
tocyte invasion. There was a positive correlation between glid-
ing and invasion inhibition (Figure S3A in Extended data14, 
P=0.005, Spearman’s ρ=0.67), suggesting that in vitro gliding 
inhibition by naturally acquired antibodies might serve as a good 
surrogate for in vitro hepatocyte invasion inhibition. Sporozoite 
invasion inhibition correlated with IgG targeting whole sporozoites 
(Figure S3B in Extended data14, P=0.004, Spearman’s ρ=0.67), 
but not with whole sporozoite IgM antibody levels (Figure S3C 
in Extended data14, P=0.13, Spearman’s ρ=0.38). There was a cor-
relation of hepatocyte invasion inhibition with CSP-specific IgG 
antibodies (Figure S3D in Extended data14, P=0.002, Spearman’s 
ρ=0.76), but not with LSA-1-specific IgG antibodies (P=0.08, 
Spearman’s ρ=0.48). 
Evidence of natural risk-modifying pre-erythrocytic 
immunity
For each immunological assay, ELISA or sporozoite gliding 
motility assays, children were categorized in two groups: 
participants with high antibody responses (or high sporozoite 
gliding inhibition activity) were those with assay values higher 
than the study population median (Figure 3A); children consid-
ered to have low antibody responses or low sporozoite gliding 
inhibition capacity had values lower than the median. Based on 
this categorization, study subjects with high CSP responses 
and those whose plasma inhibited sporozoite gliding move-
ment acquired blood-stage P. falciparum infection (qPCR-based 
parasitaemia ≥ 0.1 parasites/μl) later compared to children with 
lower CSP responses and less efficient gliding inhibitory activity 
(Figure 3B; P=0.05 and P=0.01 for CSP responses and 
sporozoite gliding inhibition, respectively). High anti-LSA-1 
antibody levels, on the other hand, did not influence time to infec-
tion (P=0.31). Blood-stage immunity, i.e. high response in the 
asexual stage lysate assay, was also associated with longer time 
to PCR-detected infection (Figure 3C, P=0.005). We repeated 
these analyses excluding children with haemoglobin S and 
haemoglobin C mutations, as these conditions might influence 
both immunity15 and parasite carriage16,17. Despite the limited 
number of individuals included in this analysis (n=36), similar 
results were obtained (P=0.01 for both CSP and asexual stage 
lysate assays and P=0.05 for the sporozoite gliding inhibition 
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High CSP response 0.62 0.34–1.15 0.13
High response to asexual stage lysate 0.49 0.27–0.89 0.02
Model II 
High gliding inhibition activity 0.55 0.29–1.01 0.06
High response to asexual stage lysate 0.52 0.29–0.94 0.03
CI, confidence interval; CSP, circumsporozoite protein.
assay). Additional analyses (Extended data14) show that functional 
responses against pre-erythrocytic stages were also associated 
with infection risk when different parasite density thresholds are 
used to define infection.
Since children with high CSP responses were more likely to have 
high antibody responses to asexual blood stage parasite lysate 
compared to low CSP responders (60% versus 38.5%, respec-
tively; P=0.12), multivariate Cox proportional hazards models were 
fit to assess the mutually adjusted effects of these immune 
responses on time to infection detection (Table 2). In a model 
that also included the results of the asexual stage lysate assay, the 
relationship between anti-CSP responses and time to malaria 
infection was not statistically significant. Despite a clear trend for 
a protective effect, the association between inhibition of 
in vitro sporozoite gliding motility and time to falciparum infec-
tion also did not reach statistical significance after adjustment for 
blood-stage immunity (hazard ratio,  0.55; 95% CI, 0.29–1.01).
Discussion
In this longitudinal study in Burkina Faso, we analysed the 
associations between functional immune responses against 
pre-erythrocytic stages of malaria and the incidence of qPCR- 
detected infections in children aged 5–10 years. We observed 
that (i) schoolchildren develop antibody responses that can inter-
fere with sporozoite motility and infectivity in vitro, and (ii) those 
children with antibodies that more efficiently reduced in vitro 
sporozoite gliding motility remained uninfected for longer 
periods of time. Our epidemiological data together with the 
in vitro data provide evidence that there is partially effective 
pre-erythrocytic immunity that influences individual level infec-
tion incidence, although we cannot exclude the contribution of 
immunity against asexual blood-stage antigens to this observation.
Sterile protection against malaria can be readily demonstrated 
in human and animal experimental models7,18,19, but not follow-
ing natural malaria exposure13. Field studies showed conflicting 
evidence on whether naturally acquired immunity can result in 
delays to patency and showed no evidence for sterile immunity 
completely preventing the appearance of parasites in the blood 
stream of exposed individuals11,13. We selected children aged 
5–10, who have lower blood stage immune responses (a potential 
confounder when studying pre-erythrocytic immunity) compared 
to semi-immune adults, and who allow repeated blood sampling 
compared to toddlers. Since submicroscopic infections are preva-
lent in the area20, we used a curative dose of antimalarials to 
clear possible sub-patent infections and, upon confirmation that 
children were parasite-free at the start of the transmission 
season, assessed the infection incidence by sensitive molecular 
assays. Our finding that 98% of the cohort became infected 
with P. falciparum within 3 months confirms the high force of 
infection in the area.
Consistent with previous sero-epidemiological studies21–24, our 
results indicate that antibodies to P. falciparum sporozoite and 
liver-stage antigens are acquired following natural exposure. 
Antibody titres to the CSP antigen were on average low in 
our cohort and not significantly different from malaria-naive 
donors. These low titres could be related to the timing of the study 
recruitment (prior to the transmission season after ~7 months of 
very low malaria exposure), which would imply that responses 
to CSP are short lived. The antibody levels could also have been 
influenced by repeated blood-stage infections in our cohort, 
which may have suppressed immune responses against the 
pre-erythrocytic stages25, although, in theory, responses to both 
LSA-1 and CSP would be affected. To assess the contribution 
of pre-erythrocytic humoral immunity to protection, previous 
studies have related antibodies at baseline with time-to-infection 
after parasite clearance with antimalarials12. A significant chal-
lenge in these studies is that both protective immunity and 
cumulative exposure increase with age, and so it is often unclear 
whether measured responses mediate protection or are merely 
a marker of past exposure26,27. In an attempt to move beyond 
indirect epidemiological associations, we explored functional 
anti-sporozoite immunity by assessing the ability of plasma 
to inhibit sporozoite gliding motility28 and hepatocyte inva-
sion29 and related these in vitro phenotypes to field findings. 
We observed that CSP IgG antibodies showed a strong positive 
association with sporozoite gliding motility inhibition. It has 
been demonstrated that Plasmodium parasites use the system of 
adhesion-based motility, gliding, to actively penetrate host 
cells30; and that the invasive ability of sporozoites is associ-
ated with their motility31. In agreement with these findings, the 
data presented here suggest that in vitro gliding inhibition by 
naturally acquired antibodies may be a useful surrogate marker 
for in vitro hepatocyte invasion. In an immuno-epidemiological 
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study undertaken in Indonesia, hepatocyte invasion inhibition was 
associated with higher anti-CSP antibody titres32. In our cohort, 
subjects with high CSP responses (i.e. higher than the study 
population median) and those whose plasma more efficiently 
inhibited sporozoite gliding movement developed P. falciparum 
infection later compared to children with lower responses. To our 
knowledge, this is the first study to show that there are functional 
antibodies against pre-erythrocytic malaria stages in malaria-
exposed children.
Our study has several limitations. We observed that high responses 
in the asexual stage lysate assay with unknown functionality 
were also associated with longer time to infection. We thus can-
not rule out a supportive role for asexual antibody responses in the 
observed associations33. Indeed, as pointed out by one of the 
reviewers of the first version of this manuscript, 17/29 (58.6%) 
children with high anti-sporozoite responses in either CSP- 
specific or sporozoite gliding assays had above-median asexual 
lysate responses versus 8/22 (36.4%) children with below-median 
anti-sporozoite activities. We  believe it is likely that the function-
ally important pre-erythrocytic antibody responses that we quan-
tified here are acquired alongside anti-blood-stage antibodies. In 
addition, a recent study in the same geographical area dem-
onstrated that heterogeneity in mosquito exposure contributes 
considerably to heterogeneity in parasite inoculation risk34. In the 
current study, we used delayed time to blood-stage infection as a 
simplistic indicator of partial protection, which fails to take into 
account variation in exposure. In an ideal approach, we would 
have been able to quantify malaria exposure at an individual 
level, which may involve linking of blood meals in household-
caught mosquitoes to household occupants and determining spo-
rozoites in the salivary glands of these mosquitoes35. Measuring 
exposure at individual level in such an approach will help to 
shed further light on pre-erythrocytic immunity in naturally 
exposed individuals. With respect to discriminating between pre- 
erythrocytic and blood-stage immunity, a valuable but laborious 
approach would be to examine the observed relationships in a 
larger cohort that allows stratification based on similar blood stage 
immunity but different levels of pre-erythrocytic immunity at 
baseline and that provides sufficient power to detect weaker asso-
ciations. Another limitation of our study is that we were only 
able to determine humoral responses. Cellular responses to pre- 
erythrocytic stages have been implicated in malaria protection 
in multiple studies36,37. It is conceivable that by quantifying both 
antibody and cellular responses we would be able to better define 
natural immunological phenotypes associated with differential 
malaria risk38. Immunity to mosquito saliva might have also influ-
enced sporozoite invasion although the magnitude of such an effect 
compared to the established impact of anti-sporozoite responses 
is currently unknown and it is currently unknown whether this 
would require responses to antigens that are conserved between 
A. stephensi mosquitoes used for sporozoite production and 
vectors that study participants were naturally exposed to 39.
In summary, in our cohort of children, anti-CSP antibodies 
were strongly associated with in vitro sporozoite gliding 
inhibition and hepatocyte invasion inhibition. Children with 
functional anti-sporozoite antibody responses had a longer time to 
P. falciparum infection compared to children with lower func-
tional responses, suggesting that these in vitro assays are 
relevant to understand natural protection. The partial protection 
(i.e., delay in infection) observed in our study does not prevent 
individuals from becoming infected during an entire transmission 
season, but reduces infection incidence and consequently needs 
to be considered in epidemiological studies aiming to under-
stand malaria risk heterogeneity and in malaria vaccines trials. 
Identifying host or parasite factors linked to these functional immu-
nological phenotypes and characterizing how these phenotypes 
change with cumulative exposure to malaria parasites will help the 




This study was performed from June to December 2015 in the 
village of Balonghin in the Saponé health district, Burkina Faso, 
which is exposed to intense and seasonal P. falciparum trans-
mission20. Written informed consent was provided by the parent 
or guardian of each child. The study was approved by the ethics 
committees of the London School of Hygiene and Tropical 
Medicine (reference number 9008) and the Ministry of Health 
in Burkina Faso (reference number 2015-3-033). Children 
aged 5–10 years with haemoglobin levels above 8 g/dl and no 
Plasmodium parasites detected by microscopy were eligible. 
DHA-PQ was used to clear sub-microscopic infections. At 3 
weeks (20–22 days) after treatment, finger-prick blood samples 
were collected to ensure parasite negativity by nested PCR40 
prior to formal enrolment into the cohort. Citrated plasma sam-
ples were collected before treatment using citrated vacutainer cell 
preparation tubes (CPT vacutainers, Becton Dickinson), stored 
at -80°C and used for malaria-antigen-specific IgG ELISAs 
and sporozoite assays. Peripheral blood mononuclear cells 
(PBMC) were also collected, but were lost due to the inabil-
ity to maintain liquid nitrogen supplies during civil unrest in 
Ouagadougou. Following enrolment, participants were examined 
during weekly visits, when finger-prick samples were collected 
for P. falciparum nested PCR that was performed within 48 hours. 
Following parasite detection, finger-prick blood samples were 
collected every day for 1 week, and every week afterwards, up to 
35 days after parasite detection. Study participants were closely 
monitored for the development of malaria symptoms. Artemether- 
lumefantrine was given upon the detection of symptoms or 
35 days after initial detection of infection by nested PCR, 
whichever came first. For the current analyses, only the time 
to first infection detection was used and related to baseline 
immunological assays.
Molecular analyses
Nucleic acids from 100 μl whole-blood samples stored in 
RNAprotect Cell Reagent were extracted using MagNAPure LC 
automatic extractor (Total Nucleic Acid Isolation Kit—High 
Performance, Roche Applied Science) and used for qPCR tar-
geting 18S rRNA41. Genomic DNA from the same extraction 
was used to test for human haemoglobinopathies haemoglobin 
S and C42.
Parasite culture and generation of P. falciparum-infected 
mosquitoes
As source of sporozoites, Anopheles stephensi mosquitoes were 
infected by standard membrane feeding on P. falciparum NF54 
gametocyte cultures43. Salivary glands from infected mosquitoes 
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were dissected, collected in Leibovitz culture medium (Lonza) 
without serum (supplemented with 1% penicillin-streptomycin 
and 1% L-glutamine for in vitro gliding motility assays), and 
homogenized in a homemade glass grinder. The number of 
sporozoites was counted in a Bürker-Türk counting chamber using 
phase contrast microscopy18.
Human hepatoma HC-04 cell line
The HC-04 human hepatoma cell line29 was acquired through 
MR4 as part of the Biodefense and Emerging Infections 
Research Resources Repository (BEI Resources). Hepatoma 
cells (referred to as hepatocytes) were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM)/Ham’s F-12 nutrient mix-
ture medium (GIBCO) supplemented with 10% heat-inactivated 
fetal bovine serum (FBS, GIBCO), 1% glutamine and 1% 
penicillin/streptomycin (GIBCO) at 37°C in an atmosphere of 
5% CO2.
Enzyme-linked immunosorbent assays and sporozoite 
opsonization assays
Levels of antibodies were determined to circumsporozoite 
protein (CSP: full-length P. falciparum NF54 CSP with repeats, 
produced in E. coli by Gennova Biopharmaceuticals Ltd., 
Pune, India), LSA-1 (LSA-NRC construct expressed in E. coli) 
and asexual lysate using previously reported standardized 
enzyme-linked immunosorbent assays (ELISAs)44,45 in naturally 
exposed children (n=51) and malaria-naive European donors 
(n=9). Antibody levels were calculated in relation to the posi-
tive control (hyperimmune plasma pool from Tanzania) that was 
set at 100 arbitrary units (AU) using Auditable Data Analysis and 
Management System (ADAMSEL, version 1.1)19.
Recognition of whole sporozoites by naturally acquired IgG 
and IgM antibodies was determined by an in vitro flow- 
cytometry-based antibody opsonization assay that was presented 
in detail elsewhere46. Due to limited plasma availability and avail-
able sporozoite numbers, 16 naturally exposed children with 
highest (8) and lowest (8) gliding activity were selected for spo-
rozoite opsonization assays and invasion assays, allowing us 
to investigate potential correlations. Flow cytometric analysis 
was performed  with a LSRII flow cytometer (BD BioSciences); 
data analysis by FlowJo software (version 10.0.8, Tree Star).
Malaria-naive donors are healthy malaria-naive European vol-
unteers who participated in CPS-immunization trial (immuni-
zation of malaria-naive human volunteers under chloroquine 
prophylaxis with sporozoites delivered by mosquito bites) 
at the Radboud University Medical Center (Nijmegen, The 
Netherlands)47. Written informed consent was obtained from 
these individuals including for their samples to be stored and 
used in additional immunological experiments. Pre-immunization 
samples collected before the CPS-immunization were used for 
analysis of malaria antigen-specific antibody levels.
In vitro sporozoite gliding motility assay
Prior to in vitro sporozoite assays, plasma aliquots were 
heat-inactivated for 30 minutes at 56°C, centrifuged at 13,000 rpm 
for 5 minutes at room temperature and kept at 4°C. Flat-bottom 
optical-bottom 96-well plates with cover glass base were incu-
bated overnight at 4°C with an anti-CSP monoclonal antibody 
(produced at Radboudumc Nijmegen, Netherlands48) 3SP2; 
5 μg/ml in PBS). Following incubation, wells were washed twice 
with 150 μl/well PBS, blocked for 20 minutes at room temperature 
with 100 μl/well Leibovitz medium (Lonza) supplemented with 
1% penicillin-streptomycin (GIBCO), 1% L-glutamine (GIBCO) 
and 10% heat-inactivated FBS(GIBCO). P. falciparum NF54 
sporozoites (100 μl) were pre-incubated with citrated samples 
(70 μl; 40% final concentration) for 30 minutes at room tempera-
ture and added to each well in triplicate (50 μl/well) at a concen-
tration of 10,000 sporozoites/well. Sporozoites were allowed to 
glide for 90 minutes at 37°C, 98% humidity, 93% N2, 4% CO2 
and 3% O2. Wells were washed thrice with 100 μl/well PBS and 
gliding trails were fixed for 15 minutes at room temperature 
with 4% paraformaldehyde (Affymetrix). Following fixation, 
wells were washed thrice with 100 μl/well PBS and blocked with 
150 μl/well 10% FBS/PBS for 20 minutes at room temperature. 
Subsequently, gliding trails were stained for 1 hour at room 
temperature with 50 μl/well 5 μg/ml biotinylated anti-CSP 
monoclonal antibody (anti-CSP 3SP2 antibodies were produced at 
Radboudumc, Nijmegen, the Netherlands48), followed by a wash 
step (thrice with PBS) and a 1 hour incubation at room tempera-
ture with 50μl/well 10 μg/ml streptavidin-Alexa Fluor-594 (Life 
Technologies) diluted in 10% FBS in PBS. Subsequently, 
wells were washed thrice with 100 μl/well PBS and stored in 
150 μl/well PBS at 4°C in the dark until analysis. Gliding trails 
were imaged automatically with the BioTek Cytation cell 
imager (25 images per well at 200x magnification) and images 
were analysed automatically by FIJI software (under ImageJ 
version 2.0.0-rc-68/1.52h) with Otsu’s thresholding28. Results 
were plotted in GraphPad Prism version 5.03.The number of 
pixels present on a stitched image made from 25 individual 
pictures taken per well is a measure of the amount of shed 
CSP in that particular well and therefore, differences in the 
number of pixels can be interpreted as differences in sporozoite 
gliding trail surface28.
In vitro sporozoite infectivity assay of a human hepatoma 
cell line
Neutralization of P. falciparum sporozoite hepatocyte invasion by 
naturally acquired antibodies was assessed in a flow-cytometry- 
based in vitro invasion assay, as previously described with small 
adaptations46. Briefly, freshly dissected P. falciparum NF54 
sporozoites were added to heat-inactivated plasma samples (10% 
final concentration) from malaria-naive or malaria-exposed indi-
viduals and pre-incubated for 30 minutes at 4°C. Subsequently, 
the sporozoite-plasma mixtures (5.104 sporozoites in the presence 
of 10% plasma) were added to HC-04 hepatocytes in 96-well 
plates. Following 3 hours of incubation at 37°C in 5% CO2, 
invaded and intracellular sporozoites were stained with an Alexa 
Fluor 488-conjugated anti-CSP antibody. Flow cytometric analy-
sis was performed with a Gallios (Beckman Coulter) flow cytom-
eter and data were analysed with FlowJo software (version 
10.0.8, Tree Star). The percentage of CSP-positive hepatocytes 
was first corrected for background reactivity by subtracting the 
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background (uninfected HC-04 cells in the presence of 3SP2- 
Alexa Fluor-488 antibody). The percent invasion inhibition 
was expressed relative to control IgG.
Statistical analysis
For analysis of in vitro sporozoite data, comparisons between 
two (controls versus field samples) or multiple groups were 
performed using Mann-Whitney U-test and Kruskal-Wallis test 
followed by Dunn’s test between two groups, respectively. The 
associations between immune responses and malaria infection 
risk were assessed using survival analysis methods. Log-rank 
test was used to compare times to infection incidence for indi-
viduals with different values of immune phenotypes. Cox survival 
models were fit to assess the effect of pre-erythrocytic immu-
nity after adjustment for blood-stage immunity; the proportional 
hazards assumption was tested using Schoenfeld residuals. In 
these analyses, study participants were considered to have high or 
low responses (binary explanatory variables) based on the study 
population median (see Figure S5 in Extended data14). The 
first scheduled weekly visit or intensive follow-up visit when 
parasitaemia of at least 0.1 parasites per μl was detected by 18S 
qPCR was considered the time of infection incidence. Using this 
criterion, the median 18S qPCR-based parasitaemia at infection 
detection was 2.2 parasites per μl and the interquartile range 
was 0.4 – 80.4. This threshold of parasitaemia was chosen to 
minimise false-positive results. In the supplemental material, sen-
sitivity analyses were included that used different cut-offs of 18S 
qPCR-based density to determine infection positivity. Stata 14 
(StataCorp LP, Texas,  USA) and GraphPad Prism software (ver-
sion 5, GraphPad Software Inc., California, USA) were used for 
statistical analysis. P<0.05 was considered statistically significant.
Data availability
Underlying data
The main dataset relating to the field study contains individual 
level data and identifying information on participants; as such, 
this dataset is stored under restricted access and not available 
through an open-access repository. Requests from researchers to 
access these data for pooled or meta-analysis should be addressed 
to the corresponding author (teun.bousema@radboudumc.nl). 
However, the dataset used in the survival analysis has been 
de-identified and is available from the Dryad repository, along 
with raw ELISA results and sporozoite gliding data. DOI: 
https://dx.doi.org/10.5061/dryad.n1m33qq14.
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
Extended data
The results of sensitivity analyses (see Results section) and 
Figure S1–Figure S5 are available from the Dryad repository.
Figure S1. Correlation analyses of naturally acquired whole 
sporozoite IgG and IgM antibodies. (A) Scatter plot of whole 
sporozoite IgG and IgM antibodies targeting P. falciparum 
NF54 sporozoites is shown (n=17). (B) Correlation analysis for 
P. falciparum NF54 sporozoite and CSP-specific IgG antibodies as 
determined by ELISAs is shown.
Figure S2. Antibody specificity and in vitro gliding inhibition 
by naturally acquired antibodies. (A). Scatter plot of in vitro 
gliding inhibition and CSP-specific IgG antibodies as determined 
by ELISAs is shown (n=51). Samples selected for additional 
invasion experiments had either poor (orange) or strong (green) 
gliding inhibitory activity. Correlation analysis for whole sporo-
zoite (B) IgG or (C) IgM antibodies and in vitro gliding inhibi-
tion by naturally acquired antibodies was conducted with samples 
from 16 children. Recognition of P. falciparum NF54 sporozoites 
by whole sporozoite (D) IgG and (E) IgM antibodies from natu-
rally exposed children (n= 16) or malaria-naive adults (n=8) 
was shown as the geometric mean fluorescent intensity (MFI) 
and divided in subgroups: malaria-naive adults (black), poor 
(orange) versus strong gliding inhibitors (green). Correlation 
analyses were conducted with Spearman correlation analysis. 
Comparisons between multiple groups were tested by Kruskal 
Wallis test.
Figure S3. Inhibition of in vitro sporozoite invasion of 
hepatocytes by antibodies from children in Burkina Faso. 
Gliding motility and invasion of P. falciparum NF54 sporozoites 
pre-treated with plasma from children from Burkina Faso and 
malaria-naive adults was determined by in vitro gliding motility 
and invasion assays in human hepatoma cells. (A) Scatter plot of 
in vitro gliding and invasion inhibition by naturally acquired 
antibodies is shown. Additionally, correlation analyses of the 
percent invasion inhibition with whole sporozoite (B) IgG, (C) 
IgM antibodies or (D) CSP-specific IgG antibodies is shown. 
Children whom had poor or strong neutralizing effect on spo-
rozoite infectivity are shown in orange and green circles, 
respectively.
Figure S4. CSP antibody levels versus immune responses 
against asexual stage antigens. In this figure, the x-axis shows CSP 
antibody levels; the y-axis represents antibody responses against 
asexual stage parasites lysate. Both axes are in log-scale; one 
child with undetectable CSP response is not included in this graph.
Figure S5. Distribution of immune phenotypes. The distribu-
tions of log10-transformed antibody responses (x-axes) against 
CSP, LSA-1 and asexual blood stage lysate (AL) are presented in 
panels (A), (B) and (C). The y-axes in these panels represent the 
percentages of study population with various levels of responses. In 
(A) and (B), one and seven individuals had undetectable responses 
and, to be included in this figure, were assigned response values 
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equivalent to half of the lower limit of detection. In (D), the results 
of gliding assays are presented: the left plot presents the distri-
bution of log10-transformed sporozoite gliding surface; the right 
plot shows gliding inhibition (y-axis) for each study participant 
(different bars; x-axis). The median gliding inhibition (59.6%) was 
used to define high and low inhibition in the survival analysis.
DOI: https://doi.org/10.5061/dryad.n1m33qq.214. 
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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This also applies to the main Introduction. Although sterilizing immunity does not







We now modified two similar sentences in the   and  section:Abstract Introduction 
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 We now modified two similar sentences in the   and  section:Abstract Introduction 
 
“Individuals living in malaria-endemic regions develop naturally acquired immunity against severe
malarial disease, but it is unclear whether immunity against pre-erythrocytic stages that blocks
 develops following continuous naturalinitiation of blood-stage infection after parasite inoculation
exposure.” (Abstract)
 
“Individuals living in malaria-endemic regions can develop naturally acquired immunity against
severe malaria disease and death, but it is unclear whether immunity that reduces, entirely or
 develops followingpartially, the probability of blood-stage infection after parasite inoculation




“In the Abstract Methods it would be relevant to specify the intensity of malaria
transmission and the specific area of study (location) within Burkina Faso, to know how
repeatedly are they exposed to Pf. Also clarify if it is qPCR or nested PCR (also in results,
it is a bit confusing when each is used). Liver stage antigen: which one? Specify also that
the functional sporozoite assays are in vitro.
 
In the results, mention if CSP antibody titres correlated with hepatocyte invasion and if






“We cleared schoolchildren living in an area (health district of Saponé, Burkina Faso) with highly
 of possible sub-patent infections and examined them weekly forendemic seasonal malaria
incident infections by PCR. Plasma samples collected at enrolment were used to quantifynested 
antibodies to the pre-erythrocytic-stage antigens circumsporozoite protein (CSP) and iver stageL
antigen . porozoite gliding inhibition by naturally acquired antibodies was1 (LSA-1) In vitro s
assessed using Plasmodium falciparum NF54 sporozoites; hepatocyte invasion was assessed
using the human HC-04 hepatoma cell line and NF54 sporozoites. The associations between 
functional pre-erythrocytic immunity phenotypes and time to infectionantibody responses, humoral 
were studied.”detected by 18S quantitative PCR 
 
We have also included information on the correlation between  hepatocyte invasionin vitro 
inhibition and anti-CSP antibody levels:
 
“In vitro hepatocyte invasion was inhibited by naturally acquired antibodies (median invasion
inhibition, 19.4% [IQR 15.2-40.9%]), and there  positive correlation  between invasionwere s
inhibition  (P=0.0 , Spearman’s ρ=0.6 )and gliding inhibition 05 7  and between invasion inhibition and
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 “INTRODUCTION









Can it be clarified if children did not receive antimalarial treatment, if during the weekly
monitoring visits the nested PCR (done 48h after bleeding) was Pf positive but they had
no symptoms (at least for 35 days)? If so, this was accepted by ethics committees easily?































than a year (Moss et al. Malaria Epidemiology and Control Within the International Centers of
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When presenting data on median invasion inhibition, please comment on whether these %








assay and  infection incidence, semi-quantitative statements of this type are difficult toin vivo 
interpret. Some studies that performed the same  assay were cited:in vitro 
 
Behet et al. The complement system contributes to functional antibody-mediated responses
. Infect Immun. 2018induced by immunization with Plasmodium falciparum malaria sporozoites
 
Sattabongkot et al. Establishment of a human hepatocyte line that supports in vitro development of
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 Sattabongkot et al. Establishment of a human hepatocyte line that supports in vitro development of





“The following statement does not look convincing by looking at the Fig S3A scatter plot
despite the P=0.02 and Spearman’s ρ=0.60 that appears driven by extreme values: "There
was a positive correlation between gliding and invasion inhibition suggesting that in vitro
gliding inhibition by naturally acquired antibodies might serve as a good surrogate for in









“7/8 plasma samples from strong gliding inhibitors reduced hepatocyte invasion by 20% or more,
There was awhereas only 2/8 poor gliding inhibitors inhibited at least 20% of hepatocyte invasion. 
positive correlation between gliding and invasion inhibition (Figure S3A in Extended data14,
P=0.005, Spearman’s ρ=0.67), suggesting that in vitro gliding inhibition by naturally acquired




“Fig 3A: interesting to see that there is not always overlap of the three metrics, expected













“Explain the rationale for categorizing in high and low responders. Was the analysis also
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“The joint analysis of the antibody levels to CSP and blood stage lysate and the functional
pre-erythrocytic responses is helpful, but shouldn't there be a model with the 3-4












It is not convincing to say that children 5-10 years in a highly endemic area of Burkina
Faso have limited blood stage immunity. They will have quite high antibody responses to






children aged 5–10, who have limited blood stage immunity (a potential confounder when studying
.”. We have now modified thepre-erythrocytic immunity) compared to semi-immune adults, …
sentence to avoid misinterpretation:
 
“We selected children aged 5–10, who have (a potentiallower blood stage immune responses 
confounder when studying pre-erythrocytic immunity) compared to semi-immune adults, and who





“It is surprising the lack of difference in antibody levels for CSP between these children
and naive volunteers. Even if CSP is not as highly immunogenic as many blood stage
antigens, the responses are usually significant and detectable, even in children. Could
there be a problem with the capture antigen? Seasonality by itself may not totally explain
this, or it would imply they are very short lived. The potential inhibition by blood stage has








“These low titres could be related to the timing of the study recruitment (prior to the transmission
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 “These low titres could be related to the timing of the study recruitment (prior to the transmission
season after ~7 months of very low malaria exposure), which would imply that responses to CSP
influenced by repeated blood-stageare short lived. The antibody levels could also have been 
infection  in our cohort, which may have suppressed immune responses against thes











“It is not well discussed how the affection of gliding and invasion before liver stage is
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This ms measures antibody responses in Burkinabe children after drug clearance and subsequent 
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Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes









I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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 I have read this submission. I believe that I have an appropriate level of expertise to confirm that





“This ms measures antibody responses in Burkinabe children after drug clearance and
subsequent Plasmodium falciparum infections, then attempts to explain delays in time to
infection in terms of antibodies against circumsporozoite protein (CSP) and whole
parasites.  The authors demonstrate that, in individuals who show greatest delays in time
to parasitemia, there were stronger functional antibody responses against sporozoites
which reduced gliding motility and liver cell invasion in vitro.  The major question
addressed in this ms is whether these anti-sporozoite responses are affecting time to
parasitemia in these children.  From the data presented, the answer is “maybe”.  The
problem the authors face is that for almost every infection that stimulates anti-sporozoite
antibodies, that infection also stimulates blood stage antibodies as the infection
progresses.  It is these latter that show the best negative correlation in reduction in time
to parasitemia, and while separating out the functional anti-sporozoite effects is
informative it is not definitive.  This is illustrated in Figure 3A, where of the 29 participants
with anti-sporozoite functional activities in one or both of the assays, 17 also have higher
than median anti-blood stage responses.  I do not see a way around this at the participant
level and the authors clearly acknowledge this difficulty in their discussion; one is trying
to see subtle effects on infection (in this case time to infection no children we uninfected
during the study) using markers that autocorrelated and cannot therefore be separated
from one another in terms of cause and effect.
 
One additional complication is not considered as far as I can tell.  In order to have become
infected, these children must have been bitten by mosquitoes.  The mosquito bites induce
antibody responses.  The sporozoites used in the assays for gliding motility and
hepatocyte invasion were from crude homogenates that contain salivary gland material.  It
is possible (though I admit not too likely) that there was some functional interaction
between these two.  Could antibodies against (Anopheles stephensi) salivary glands be
present in these sera (of children bitten by African anophelines), and if so, could they
have affected the in vitro functional antibody assays?
 
Nevertheless, the ms provides important information concerning anti-sporozoite









“We observed that high responses in the asexual stage lysate assay with unknown functionality
were also associated with longer time to infection. We thus cannot rule out a supportive role for
asexual antibody responses in the observed associations. Indeed, as pointed out by one of the
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 were also associated with longer time to infection. We thus cannot rule out a supportive role for
asexual antibody responses in the observed associations. Indeed, as pointed out by one of the
reviewers of the first version of this manuscript, 17/29 (58.6%) children with high anti-sporozoite
responses in either CSP-specific or sporozoite gliding assays had above-median asexual lysate






both the viability of sporozoites (Dragovic et al. Immunization with AgTRIO, a Protein in Anopheles
 Cell, Host & Microbe 2018)Saliva, Contributes to Protection against Plasmodium Infection in Mice.
and (not the topic of this paper) the transmission of parasites from man to mosquito (Yamamoto et






Moreover, the  work that we have done is based on sporozoites harvested from in vitro Anopheles
, that is not present in West Africa (see Sinka et al. stephensi A global map of dominant malaria
Parasites & Vectors. 2012). Whilst many salivary proteins appear to be conserved among vectors. 




saturation of responses to this protein (Stone  PLoS ONE 2012) and correlations betweenet al. 






“Another limitation of our study is that we were only able to determine humoral responses. Cellular
responses to pre-erythrocytic stages have been implicated in malaria protection in multiple studies.
It is conceivable that by quantifying both antibody and cellular responses we would be able to
better define natural immunological phenotypes associated with differential malaria risk. Immunity
to mosquito saliva might have also influenced sporozoite invasion although the magnitude of such
an effect compared to the established impact of anti-sporozoite responses is currently unknown
and it is currently unknown whether this would require responses to antigens that are conserved
between An. stephensi mosquitoes used for sporozoite production and vectors that study





Given the comments above and the stronger correlation of blood stage antibodies with
delay to parasitemia, the authors should consider changing the abstract (and perhaps the
title) to include this information.  It is buried in the paper but should be more explicit.”
 
Answer
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“Survival analysis indicated longer time to infection in individuals displaying higher-than-median
sporozoite gliding inhibition activity (P=0.01), although this association became non-significant
.after adjustment for blood-stage immunity (P = 0.06)
 
“In summary, functional antibodies against the pre-erythrocytic stages of malaria infection are
acquired in children who are repeatedly exposed to Plasmodium parasites. This immune response
does not prevent them from becoming infected during a malaria transmission season, but might
delay the appearance of blood stage parasitaemia. Our approach could not fully separate the
effects of pre-erythrocytic-specific and blood-stage-specific antibody-mediated immune responses
in vivo; epidemiological studies powered and designed to address this important question should




“At the start of the introduction, the authors highlight the protective efficacies of RTS,S
and PfSPZ Vaccine.  However, they should also note that the outcomes, efficacies are
different, RTS,S being time to clinical malaria, PfSPZ Vaccine being time to parasitemia. 







“The most advanced malaria vaccine, RTS,S (trade name, Mosquirix), induces immune responses
that target P. falciparum circumsporozoite protein (CSP)  and thereby the pre-erythrocytic stages of,





“Also in the introduction, the authors suggest that there is a discrepancy between
protection with sporozoites and naturally induced protection not preventing infection. 
However, they do not consider the obvious reason for this – dose.  Mosquitoes deliver a
few (median 50 sporozoites per bite) now and again over a transmission season, while the







“The results of this and other vaccine trials and the efficient immunisation of malaria-naive
individuals with multiple infected mosquito bites while receiving chloroquine contrast with the
limited epidemiological evidence of naturally acquired functional immunity to Plasmodium
pre-erythrocytic stages, which could be possibly linked to the lower number of sporozoites in
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 pre-erythrocytic stages, which could be possibly linked to the lower number of sporozoites in
. Individuals living innatural parasite inoculations or to the frequency of host-vector contacts
malaria-endemic regions can develop naturally acquired immunity against severe malaria disease
and death, but it is unclear whether immunity that reduces, entirely or partially, the probability of




“The authors say that there are sporozoite-specific IgG and IgM antibodies in the malaria
exposed children, but such specificity has not been demonstrated, only reactivity. T44he







“ ”Sporozoite-specific IgG and IgM antibodies in malaria-exposed children
to:




“In addition to antigen-specific assays, IgG and IgM antibodies recognizing Plasmodium
sporozoites were quantified using fluorescently labelled anti-IgG and anti-IgM antibodies by flow
cytometric analysis. hole sporozoite  were significantly higher Levels of antibodies targeting w s in
malaria-naive donors ( Figure 2D, E, P=0.01 and 0.04 for IgGthe study participants compared to 
and IgM, respectively). Strong correlations between IgG and IgM antibodies targeting whole
( Figure S1A in Extended data 14 , P=0.0005, Spearman’s ρ=0.75), and betweensporozoites 
CSP-IgG antibody levels and whole sporozoite IgG antibodies ( Figure S1B in Extended data 14 ,
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“The authors note an important variable that could not be accounted for in their studies,
namely variability in exposure.  One of the authors has worked on antibody responses to
mosquito saliva as a marker for exposure risk: would it not be possible to measure






same area (Guelbéogo et al, Variation in natural exposure to anopheles mosquitoes and its effects












Introduction, paragraph 1. The sentence ending “ but it is unclear whether immunity that
prevents or reduces infection incidence develops following natural exposure”. This is a
misuse of the term incidence – prevention of infection in one person will reduce incidence
in the population.  I think the authors mean “that prevents infection or reduces infection
intensity in an individual….”.  In the same paragraph, change the word ‘suggests’







“Individuals living in malaria-endemic regions can develop naturally acquired immunity against
severe malaria disease and death, but it is unclear whether immunity that reduces, entirely or









“Results, paragraph 2.  Should read Parasitological and immunological data from the
remaining 51 children followed intensively were…”  What does “data from this child were
censored after the onset of symptoms” mean?  Could have any one of many
interpretations.”
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“In the results section “Naturally acquired antibodies in children neutralize in vitro
sporozoite gliding motility” the authors should change the term “considerably larger’ for






“To characterize the effect of human plasma on sporozoite gliding motility that is independent of
naturally acquired immunity, sporozoites were incubated in the presence of plasma from
malaria-naive individuals (n=5) and showed an average gliding trail surface of 1,427(95% CI
646.6-2,207) pixels, than the gliding trail surface of sporozoites incubated withsignificantly greater 












“In the discussion, the authors say “To our knowledge, this is one of the first studies to
show that there are functional antibodies against pre-erythrocytic malaria stages in
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Comment 
“The authors should check the axis labeling of figures: for example (% infected) ought to
be “Percent children infected with P. falciparum”, in Figure S1 the abbreviations/units are













“…. In (B), Kaplan-Meier curves for children with high and low circumsporozoite protein (CSP)
responses and gliding inhibition (GI) phenotypes are presented ; in (C), curves for(N = 51)
participants categorized based on their responses to asexual stage antigens (AL) are shown (N =
. 51) In both panels (B) and (C), the y-axis corresponds to the percentage of the population
 ”uninfected at different time points.
 No competing interests were disclosed.Competing Interests:
 03 January 2019Reviewer Report
https://doi.org/10.21956/wellcomeopenres.16280.r34444









acquired immunity to pre-erythrocytic stages of  and I make a few comments andP. falciparum 
suggestions that may improve the current version of the manuscript. 
The data shows that ABs developed during past malaria cases can reduce sporozoite motility and
hepatocyte invasion  suggesting that ABs acquired during natural infections can reduce newin vitro 
liver-stage infections. However, the contribution of a possible similar effect  is, in my view, less clearin vivo 
from the data presented, and more caution may be needed to discuss the results. All the children followed
throughout the study became parasite positive by qPCR, indicating that even children with strong
inhibiting ABs were unable to block liver-stage infection efficiently. Furthermore, high response to asexual
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concluded that there no or very limited evidence for an age dependent acquisition of immunity protecting




At the end of section  the authors should, inEvidence of natural risk-modifying pre-erythrocytic immunity
my view, clearly state that  does not independently associate in a statisticallyHigh gliding inhibition activity


























time-point as  as I do not think that it can be excluded that the childrenPersisting parasites post-treatment
were re-infected after clearance of PQ.
I recommend adding a brief description of the method in ref 45 in the section In vitro sporozoite infectivity
inmaterial and methods.assay of a human hepatoma cell line 
1
2
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 inmaterial and methods.assay of a human hepatoma cell line 
On page 3 below table 1 there is mention to  which may be a mistake.field PCR 










Plasmodium falciparum infection. . 2013;   (1): 40-7   |   Clin Infect Dis 57 PubMed Abstract Publisher Full Text
2. Stewart MJ, Nawrot RJ, Schulman S, Vanderberg JP: Plasmodium berghei sporozoite invasion is
blocked in vitro by sporozoite-immobilizing antibodies. . 1986;   (3): 859-64 Infect Immun 51 PubMed
Abstract
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Partly




I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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“In this manuscript Barry, Behet and colleagues address an important question aiming to
possibly appoint an effective role in protection from clinical malaria to liver-stage
immunity acquired naturally in malaria endemic areas. I believe the work presented is a
significant contribution to our understanding of naturally acquired immunity to
pre-erythrocytic stages of P. falciparum and I make a few comments and suggestions that
may improve the current version of the manuscript. 
 
The data shows that ABs developed during past malaria cases can reduce sporozoite
motility and hepatocyte invasion in vitro suggesting that ABs acquired during natural
infections can reduce new liver-stage infections. However, the contribution of a possible
similar effect in vivo is, in my view, less clear from the data presented, and more caution
may be needed to discuss the results. All the children followed throughout the study
became parasite positive by qPCR, indicating that even children with strong inhibiting
ABs were unable to block liver-stage infection efficiently. Furthermore, high response to
asexual stage lysate might be confounding the analysis. I would add to the manuscript (or
supplemental) figures the association of CSP ABs with asexual stage lysate ABs, and also
the association of whole SPZ ABs with asexual stage lysate ABs, to give the reader an








“Survival analysis indicated longer time to infection in individuals displaying higher-than-median
sporozoite gliding inhibition activity (P=0.01), although this association became non-significant
.”after adjustment for blood-stage immunity (P = 0.06)
 
“In summary, functional antibodies against the pre-erythrocytic stages of malaria infection are
acquired in children who are repeatedly exposed to Plasmodium parasites. This immune response
does not prevent them from becoming infected during a malaria transmission season, but might
delay the appearance of blood stage parasitaemia. Our approach could not fully separate the
effects of pre-erythrocytic-specific and blood-stage-specific antibody-mediated immune responses
in vivo; epidemiological studies powered and designed to address this important question should




“Our epidemiological data together with the in vitro data provide evidence that there is partially
effective  immunity that influences individual level infection incidencepre-erythrocytic , although we
cannot exclude the contribution of immunity against asexual blood-stage antigens to this
.”observation
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“Figure S4. CSP antibody levels versus immune responses against asexual stage antigens. In this
figure, the x-axis shows CSP antibody levels; the y-axis represents antibody responses against
asexual stage parasites lysate. Both axes are in log-scale; one child with undetectable CSP




“To assess the effect of immune responses on infection risk, children were classified based on
whether the results of their assays were higher or lower than the study population median (see
Results): in ( A), vertically aligned cells represent the same participant, and orange cells indicate
that assay results are higher than the median (see also Figure S4, that shows a scatter plot of CSP




“I also suggest including, if that has not been done already, the Reported bed net use in















“The authors cite the study by Tran et al. where it was shown that, in Mali, time to PCR
positive was independent of age, while time to clinical malaria increased with age, and
where as stated it was concluded that there no or very limited evidence for an age
dependent acquisition of immunity protecting from infection. Similarly, in the present
manuscript, in vitro functional data of higher humoral response against pre-erythrocytic
stages does not (independently of blood-stage immunity) protect from infection. So, I
would rephrase the last sentence in first paragraph of the discussion to add a bit more
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At the end of section Evidence of natural risk-modifying pre-erythrocytic immunity the
authors should, in my view, clearly state that High gliding inhibition activity does not
independently associate in a statistically significant way, with protection against
falciparum infection on the multivariate analyses where blood stage immunity was














“ he relationshipIn a model that also included the results of the asexual stage lysate assay, t
between anti-CSP responses and time to malaria infection was not statistically significant. Despite
, inhibition of in vitro sporozoite glidinga clear trend for a protective effect the association between 
motility falciparum infection  after adjustmentand time to also did not reach statistical significance




“I believe the manuscript could be improved by presenting the quantitative analysis of the
18s qPCR upon first parasite detection and determine if there is a negative association
with the inhibitory capacity of the individuals’ ABs. It would also be very interesting to
question if time from first PCR positive to time of presentation of symptoms is different
between poor and strong in vitro inhibitors. If the in vitro data showing gliding inhibition
and reduced hepatocyte invasion are significant in vivo, one would expect a lower
inoculum in the liver and thus a lower parasitaemia on the first PCR positive time-point.
And then potentially a slower progression to clinical malaria. I believe with the data
generated in this manuscript these analyses could be done, and would enrich the story.”
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“The first scheduled weekly visit or intensive follow-up visit when parasitaemia of at least 0.1
parasites per μl was detected by 18S qPCR was considered the time of infection incidence. Using
this criterion, the median 18S qPCR-based parasitaemia at infection detection was 2.2 parasites























“It is not totally clear to me how individuals were selected for the flow cytometry assays.
Survival, gliding inhibition, CSP, LSA1 and asexual lysate ELISAs were performed for the
51 participants, but flow cytometry data presented in fig2 D and E was obtained from 17
Burkinabes only; how were those selected and what is their time to PCR+ in the survival
analysis. If they are the 8 poor and 8 strong inhibitors as defined by their gliding inhibition
it should be stated in the methods (seems to be so, given supFig3, but there is one
extra?). 
 
I also suggest to pinpoint these 8 poor and 8 strong inhibitors in fig1 so that the reader
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“Recognition of whole sporozoites by naturally acquired IgG and IgM antibodies was determined
by an in vitro flow-cytometry-based antibody opsonization assay that was presented in detail
elsewhere. Due to limited plasma availability and available sporozoite numbers, 16 naturally
exposed children with highest (8) and lowest (8) gliding activity were selected for sporozoite








“I would be more cautious when citing ref 31, I believe the study by Michael Stewart et al.
shows that non-motile SPZ are unable to invade, but is not clearly showing a direct
association between % of human AB affecting motility and those levels correlating






“It has been demonstrated that Plasmodium parasites use the system of adhesion-based motility,
gliding, to actively penetrate host cells ; and that the invasive ability of sporozoites is directly








In table 1, I would not refer to the 6 children who were PCR positive at the 3 weeks after
treatment time-point as Persisting parasites post-treatment as I do not think that it can be








“I recommend adding a brief description of the method in ref 45 in the section In vitro
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“Neutralization of P. falciparum sporozoite hepatocyte invasion by naturally acquired antibodies
was assessed in a flow-cytometry–based in vitro invasion assay as previously described with small
. adaptations Briefly, freshly dissected P. falciparum NF54 sporozoites were added to
heat-inactivated plasma samples (10% final concentration) from malaria-naive or malaria-exposed
individuals and pre-incubated for 30 minutes at 4 ˚C. Subsequently, the sporozoite-plasma
mixtures (5.10 sporozoites in the presence of 10% plasma) were added to HC-04 hepatocytes in
96-well plates. Following 3 hours of incubation at 37 ˚C in 5% CO , invaded and intracellular












“The median time from confirmation of the absence of parasites (i.e. 3 weeks after anti-malarial
treatment) to infection detection by nested PCR or onset of symptoms was 28 days; one child who




“The data from the in vitro gliding inhibition by LSA IgG seems to be not shown. I think it
should be clarified in the text that that is indeed the case. Likewise, if the LSA-1-specific
IgG antibodies correlation with sporozoite invasion inhibition is data not shown I would







“In vitro gliding inhibition did not correlate with LSA-1 IgG antibody levels (P=0.11, Spearman’s
ρ=0.23)…”
 
“ porozoite invasion inhibition correlated with IgG (Figure S3B inS targeting whole sporozoites 
Extended data14, P=0.004, Spearman’s ρ=0.67) but not with whole sporozoite IgM antibody levels
( Figure S3C in Extended data 14 , P=0.13, Spearman’s ρ=0.38). There was a correlation of
(Figure S3D in Extended data14,hepatocyte invasion inhibition with CSP-specific IgG antibodies 
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“In figS2A I would specify that is IgG in the figure x axis and use the label CSP IgG titer
instead of CSP antibody titer.
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